New guidelines for managing psoriasis with systemic medications.
D017255:Acitretin / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D007641:Keratolytic Agents; D016572:Cyclosporine; D017255:Acitretin; D008727:Methotrexate